\-\ Texto\\:\\ \ \(0\)\
\-\ hyperprolactinemia\\ without\\ elevation\\ of\\ tsh\\,\\ negative\\ hcg\\,\\ no\\ history\\ or\\ symptoms\\ of\\ cirrhosis\\,\\ renal\\ failure\\.\ \(0\)\
\-\ serum\\ calcium\\ normal\ \(0\)\
\-\ multisequence\\ mri\\ imaging\\ shows\\ subcentimeter\\ within\\ the\\ pituitary\\ gland\\.\ \(0\)\
\-\ hypointense\\ to\\ pituitary\\ on\\ both\\ pre\\ and\\ post\\-contrast\\ t1\\ imaging\\.\ \(0\)\
\-\ no\\ expansion\\ of\\ the\\ sella\\ turcica\\ or\\ encroachment\\ on\\ surrounding\\ structures\\.\ \(0\)\
\-\ pituitary\\ adenoma\ \(19\)\
\-\ pituitary\\ micoadenoma\ \(0\)\
\-\ physiologic\\ cyst\ \(0\)\
\-\ rathke\\'s\\ pouch\\ cyst\ \(0\)\
\-\ metastatic\\ disease\ \(243\)\
\-\ 34\\ yo\\ white\\ female\\ with\\ oligomenorrhea\\ and\\ galactorrhea\\ without\\ any\\ significant\\ pmh\\ or\\ fh\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ pituitary\\:\\ 0\\.2089228746738167\ \(0\)\
\-\ micoadenoma\\:\\ 0\\.10750632224349388\ \(0\)\
\-\ oligomenorrhea\\:\\ 0\\.10750632224349388\ \(0\)\
\-\ hyperprolactinemia\\:\\ 0\\.08787903062844388\ \(0\)\
\-\ galactorrhea\\:\\ 0\\.08787903062844388\ \(0\)\
\-\ multisequence\\:\\ 0\\.08071090056866194\ \(0\)\
\-\ fh\\:\\ 0\\.07942601623137137\ \(0\)\
\-\ subcentimeter\\:\\ 0\\.0772025826119329\ \(0\)\
\-\ turcica\\:\\ 0\\.0772025826119329\ \(0\)\
\-\ encroachment\\:\\ 0\\.07225788617158944\ \(0\)\
\-\ physiologic\\:\\ 0\\.07037799983223263\ \(0\)\
\-\ pre\\:\\ 0\\.06874956821486039\ \(0\)\
\-\ post\\-contrast\\:\\ 0\\.06562842950587015\ \(0\)\
\-\ pouch\\:\\ 0\\.064865986128049\ \(0\)\
\-\ rathke\\:\\ 0\\.06450192560183338\ \(0\)\
\-\ cirrhosis\\:\\ 0\\.06135766817131996\ \(0\)\
\-\ sella\\:\\ 0\\.060045099095803314\ \(0\)\
\-\ hcg\\:\\ 0\\.05863640535041497\ \(0\)\
\-\ tsh\\:\\ 0\\.056599160415498305\ \(0\)\
\-\ cyst\\:\\ 0\\.05600905209819763\ \(0\)\
\-\ pmh\\:\\ 0\\.051843539420715394\ \(0\)\
\-\ 34\\:\\ 0\\.05171716396906239\ \(0\)\
\-\ elevation\\:\\ 0\\.05146827529063303\ \(0\)\
\-\ expansion\\:\\ 0\\.051345710219248865\ \(0\)\
\-\ calcium\\:\\ 0\\.050985237021181254\ \(0\)\
\-\ serum\\:\\ 0\\.050294762704114086\ \(0\)\
\-\ hypointense\\:\\ 0\\.04943103035571637\ \(0\)\
\-\ without\\:\\ 0\\.04907349186239415\ \(0\)\
\-\ imaging\\:\\ 0\\.04883106888916104\ \(0\)\
\-\ gland\\:\\ 0\\.04438254501698377\ \(0\)\
\-\ adenoma\\:\\ 0\\.04351822380251234\ \(0\)\
\-\ failure\\:\\ 0\\.040822661985748375\ \(0\)\
\-\ structures\\:\\ 0\\.04012274981505749\ \(0\)\
\-\ or\\:\\ 0\\.03664107618159906\ \(0\)\
\-\ white\\:\\ 0\\.03456224649648802\ \(0\)\
\-\ surrounding\\:\\ 0\\.03425811298005812\ \(0\)\
\-\ t1\\:\\ 0\\.03303043336858834\ \(0\)\
\-\ any\\:\\ 0\\.032815061378930414\ \(0\)\
\-\ yo\\:\\ 0\\.031357945406131245\ \(0\)\
\-\ renal\\:\\ 0\\.03131067743241548\ \(0\)\
\-\ negative\\:\\ 0\\.031123416602132616\ \(0\)\
\-\ shows\\:\\ 0\\.02865089877718145\ \(0\)\
\-\ significant\\:\\ 0\\.028022526232368578\ \(0\)\
\-\ both\\:\\ 0\\.026612195008367336\ \(0\)\
\-\ metastatic\\:\\ 0\\.026233041507513297\ \(0\)\
\-\ symptoms\\:\\ 0\\.025971432645099258\ \(0\)\
\-\ mri\\:\\ 0\\.023942388474568536\ \(0\)\
\-\ \\'s\\:\\ 0\\.022976178272768842\ \(0\)\
\-\ female\\:\\ 0\\.021423905749363824\ \(0\)\
\-\ no\\:\\ 0\\.02098644270009273\ \(0\)\
\-\ within\\:\\ 0\\.019879651321781485\ \(0\)\
\-\ on\\:\\ 0\\.017655878350376294\ \(0\)\
\-\ disease\\:\\ 0\\.017033384648972003\ \(0\)\
\-\ normal\\:\\ 0\\.01633673725120855\ \(0\)\
\-\ history\\:\\ 0\\.014392860215940042\ \(0\)\
\-\ \\,\\:\\ 0\\.00990402678721783\ \(0\)\
\-\ to\\:\\ 0\\.005208147663938857\ \(0\)\
\-\ and\\:\\ 0\\.004390463554444352\ \(0\)\
\-\ of\\:\\ 0\\.0042623341755361616\ \(0\)\
\-\ the\\:\\ 0\\.003371933773259166\ \(0\)\
\-\ \\.\\:\\ 0\\.002164605859594285\ \(0\)\
\-\ with\\:\\ 0\\.0014268801962181675\ \(0\)\
